Contact
Please use this form to send email to PR contact of this press release:
Hagens Berman Reminds Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) of October 3, 2016 Lead Plaintiff Deadline in Securities Class Action
TO: